Impact of time from diagnosis to initiation of curative-intent chemotherapy on clinical outcomes in patients with classical Hodgkin lymphoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of time from diagnosis to initiation of curative-intent chemotherapy on clinical outcomes in patients with classical Hodgkin lymphoma
Authors
Keywords
-
Journal
LEUKEMIA & LYMPHOMA
Volume 57, Issue 4, Pages 872-879
Publisher
Informa UK Limited
Online
2015-10-14
DOI
10.3109/10428194.2015.1086919
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of time from diagnosis to initiation of curative chemotherapy on survival of patients with diffuse large B-cell lymphoma
- (2015) Kevin Hay et al. LEUKEMIA & LYMPHOMA
- Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2014) D. A. Eichenauer et al. ANNALS OF ONCOLOGY
- Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis
- (2014) K. H. Xing et al. BLOOD
- Predictors of delay in diagnosis and treatment in diffuse large B-cell lymphoma and impact on survival
- (2014) Anna Nikonova et al. BRITISH JOURNAL OF HAEMATOLOGY
- Clinical Impact of Delaying Initiation of Adjuvant Chemotherapy in Patients With Breast Cancer
- (2014) Debora de Melo Gagliato et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of Place of Residence and Treatment on Survival Outcomes in Patients With Diffuse Large B-Cell Lymphoma in British Columbia
- (2014) B. Lee et al. ONCOLOGIST
- The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)
- (2013) S. Hartmann et al. BLOOD
- Time to adjuvant chemotherapy and survival in non-small cell lung cancer
- (2012) Christopher M. Booth et al. CANCER
- Etiology of Delays in the Initiation of Adjuvant Chemotherapy and Their Impact on Outcomes for Stage II and III Rectal Cancer
- (2011) Winson Y. Cheung et al. DISEASES OF THE COLON & RECTUM
- Association Between Time to Initiation of Adjuvant Chemotherapy and Survival in Colorectal Cancer
- (2011) James J. Biagi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned
- (2011) Simonetta Viviani et al. NEW ENGLAND JOURNAL OF MEDICINE
- ABVD Alone versus Radiation-Based Therapy in Limited-Stage Hodgkin's Lymphoma
- (2011) Ralph M. Meyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study
- (2009) Andreas Engert et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Comparison of the Stanford V Regimen and ABVD in the Treatment of Advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244
- (2009) Peter J. Hoskin et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Follow-up of Survival in Hodgkin's Lymphoma
- (2009) George P. Canellos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lymphocyte-Predominant and Classical Hodgkin's Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group
- (2007) Lucia Nogová et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started